Over the last two decades coronary artery calcium (CAC) scanning has emerged as a quick, safe, and inexpensive method to detect the presence of coronary atherosclerosis. Data from multiple studies has shown that compared to individuals who do not have any coronary calcifications, those with severe calcifications (i.e., CAC score >300) have a 10-fold increase in their risk of coronary heart disease events and cardiovascular disease. Conversely, those that have a CAC of 0 have a very low event rate (~0.1%/year), with data that now extends to 15 years in some studies. Thus, the most notable implication of identifying CAC in individuals who do not have known cardiovascular disease is that it allows targeting of more aggressive therapies to those who have the highest risk of having future events. Such identification of risk is especially important for individuals who are not on any therapies for coronary heart disease, or when intensification of treatment is being considered but has an uncertain role. This review will highlight some of the recent data on CAC testing, while focusing on the implications of those findings on patient management. The evolving role of CAC in patients with diabetes will also be highlighted.

Citations

Citations to this article as recorded by  

• Artificial Intelligence in Coronary Artery Calcium Scoring Detection and Quantification
  Khaled Abdelrahman, Arthur Shiyovich, Daniel Huck, Adam Berman, Brittany Weber, Sumit Gupta, Rhanderson Cardoso, Ron Blankstein
  Diagnostics.2024; 14(2): 125.     CrossRef
• Association of Strict Versus Lenient Cholesterol Lowering with Cardiac Outcomes, Diabetes Progression and Complications, and Mortality in Patients with Diabetes Treated with Statins: Is Less More?
  Victoria Odeleye, Omar Masarweh, Jorge Restrepo, Carlos A Alvarez, Ishak A. Mansi
  Drug Safety.2023; 46(11): 1105.     CrossRef
• Impact of coronary artery calcium testing on patient management
  Wanda Y. Wu, David W. Biery, Adam N. Berman, Grace Hsieh, Sanjay Divakaran, Sumit Gupta, Michael L. Steigner, Ayaz Aghayev, Hicham Skali, Donna M. Polk, Jorge Plutzky, Christopher P. Cannon, Marcelo F. Di Carli, Ron Blankstein
  Journal of Cardiovascular Computed Tomography.2022; 16(4): 303.     CrossRef
• Application of ensemble machine learning algorithms on lifestyle factors and wearables for cardiovascular risk prediction
  Weiting Huang, Tan Wei Ying, Woon Loong Calvin Chin, Lohendran Baskaran, Ong Eng Hock Marcus, Khung Keong Yeo, Ng See Kiong
  Scientific Reports.2022;[Epub]     CrossRef
• The Influence of Obesity and Metabolic Health on Vascular Health
  Eun-Jung Rhee
  Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
• The role of cardiac computed tomography in predicting adverse coronary events
  Maria Emfietzoglou, Michail C. Mavrogiannis, Athanasios Samaras, Georgios P. Rampidis, George Giannakoulas, Polydoros N. Kampaktsis
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score
  Damiano Rizzoni, Claudia Agabiti-Rosei, Carolina De Ciuceis, Gianluca Edoardo Mario Boari
  High Blood Pressure & Cardiovascular Prevention.2022; 30(1): 17.     CrossRef
• Coronary Artery Calcium Score: Current Efficacy of Cardiac CT in Patients at Hail Region, Saudi Arabia
  Qurain Turki Alshammari, Ohood Alrashidi, Wed Almutairi, Eman Alshammari, Meshari T. Alshammari, Shashi Kumar CG, Mohammed Salih, Abdelmoneim Sulieman, Moawia Gameraddin, Bushra Abdul Malik, Amjad R. Alyahyawi
  International Journal of Pharmaceutical Research And Allied Sciences.2022; 11(3): 132.     CrossRef
• The co-existence of diabetes and subclinical atherosclerosis in rural central Appalachia: Do residential characteristics matter?
  Hadii M. Mamudu, Antwan Jones, Timir K. Paul, Fenose Osedeme, David Stewart, Arsham Alamian, Liang Wang, Sylvester Orimaye, James Bledsoe, Amy Poole, Gerald Blackwell, Mathew Budoff
  Journal of Diabetes and its Complications.2021; 35(4): 107851.     CrossRef
• Usefulness of skin advanced glycation end products to predict coronary artery calcium score in patients with type 2 diabetes
  Alejandra Planas, Olga Simó-Servat, Jordi Bañeras, Mónica Sánchez, Esther García, Ángel M. Ortiz, Marisol Ruiz-Meana, Cristina Hernández, Ignacio Ferreira-González, Rafael Simó
  Acta Diabetologica.2021; 58(10): 1403.     CrossRef
• Value of addition of coronary artery calcium to risk scores in the prediction of major cardiovascular events in patients with type 2 diabetes
  Barak Zafrir, Walid Saliba, Rachel Shay Li Widder, Razi Khoury, Elad Shemesh, David A. Halon
  BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
• Coronary Artery Calcium Score - A Reliable Indicator of Coronary Artery Disease?
  Devarashetty Shreya, Diana I Zamora, Gautami S Patel, Idan Grossmann, Kevin Rodriguez, Mridul Soni, Pranay K Joshi, Saawan C Patel, Ibrahim Sange
  Cureus.2021;[Epub]     CrossRef
• Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling
  Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
  Biochemical and Biophysical Research Communications.2020; 530(2): 374.     CrossRef
• Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies
  Khaled M. Abdelrahman, Marcus Y. Chen, Amit K. Dey, Renu Virmani, Aloke V. Finn, Ramzi Y. Khamis, Andrew D. Choi, James K. Min, Michelle C. Williams, Andrew J. Buckler, Charles A. Taylor, Campbell Rogers, Habib Samady, Charalambos Antoniades, Leslee J. Sh
  Journal of the American College of Cardiology.2020; 76(10): 1226.     CrossRef
• Optimizing coronary artery calcium scanning to meet the challenges of population screening
  Andrew J. Einstein
  Journal of Cardiovascular Computed Tomography.2019; 13(6): 303.     CrossRef
• Usefulness of the Coronary Artery Calcium Score in Predicting Subsequent Coronary Interventions—A Ten-Year Single-Center Perspective
  Agnieszka Mlynarska, Rafal Mlynarski, Maciej Sosnowski
  International Journal of Environmental Research and Public Health.2019; 16(12): 2132.     CrossRef
• Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making
  Sudipa Sarkar, Olusola A. Orimoloye, Caitlin M. Nass, Roger S. Blumenthal, Seth S. Martin
  Journal of General Internal Medicine.2019; 34(11): 2643.     CrossRef
• CT coronary imaging–a fast evolving world
  P Rajiah, S Abbara
  QJM: An International Journal of Medicine.2018; 111(9): 595.     CrossRef
• Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
  Eun-Jung Rhee
  Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
• Diabetes, subclinical atherosclerosis and multiple cardiovascular risk factors in hard-to-reach asymptomatic patients
  Hadii M Mamudu, Arsham Alamian, Timir Paul, Pooja Subedi, Liang Wang, Antwan Jones, Ali E Alamin, David Stewart, Gerald Blackwell, Matthew Budoff
  Diabetes and Vascular Disease Research.2018; 15(6): 519.     CrossRef
• Calcium detection, its quantification, and grayscale morphology-based risk stratification using machine learning in multimodality big data coronary and carotid scans: A review
  Sumit K. Banchhor, Narendra D. Londhe, Tadashi Araki, Luca Saba, Petia Radeva, Narendra N. Khanna, Jasjit S. Suri
  Computers in Biology and Medicine.2018; 101: 184.     CrossRef
• Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study
  Eun-Jung Rhee, Jung-Hwan Cho, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
  The Journal of Clinical Endocrinology & Metabolism.2017; 102(12): 4634.     CrossRef
• Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
  Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser
  PLOS ONE.2017; 12(7): e0180118.     CrossRef